Alkermes

Alkermes plc is a global biopharmaceutical company based in Dublin, Ireland, specializing in the development, manufacturing, and commercialization of innovative medicines for psychiatric and neurological disorders. Founded in 1987, the company has research and development facilities in Waltham, Massachusetts, and a manufacturing site in Wilmington, Ohio. Alkermes focuses on central nervous system (CNS) diseases, aiming to address unmet medical needs through patient-inspired science. The company develops proprietary medicines for chronic CNS conditions, including schizophrenia, bipolar I disorder, alcohol dependence, and opioid dependence. Key marketed products include Aristada and Vivitrol. Alkermes also has an active pipeline with investigational candidates for conditions such as narcolepsy and idiopathic hypersomnia. The company emphasizes a patient-centric approach, integrating research and specialized commercial infrastructure to bring innovative therapies to market.